Delivery Order SPE2DB20D1100-SPE2DB25FD9Q3
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order valued at $20,048.58 to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits. This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of September 12, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026,...
- The Defense Logistics Agency awarded a delivery order valued at $9,014.39 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 3.75 mg kits. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 31, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lupron Depot is a leuprolide acetate-based pharmaceutical product used in hormonal therapies, and this order represents a single delivery transaction under the...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lupron Depot 3.75 mg kits, valued at $15,025.58 under a firm fixed-price contract type. The order, which has an ultimate completion date of July 29, 2025, represents a non-set-aside award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $37,809.82 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 3.75 mg kits. This is a firm fixed-price, non-set-aside contract with a performance location in Conshohocken, Pennsylvania, and an ultimate completion date of August 5, 2025. Lupron Depot is a gonadotropin-releasing hormone agonist used in medical treatment, and this delivery order represents a discrete fulfillment under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,009.28 to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with a completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,949.64 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,491.62 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Lupron Depot 3.75 mg kits. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $13,424.46 for a kit of Lupron Depot (leuprolide acetate), a hormone treatment medication, under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain. The award, issued on July 23, 2025, with an ultimate completion date of the same day, represents a competitively awarded, non-set-aside contract. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,331.98 to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits under a firm fixed price contract. The award was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a non-set-aside award issued competitively to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company is headquartered. Lupron Depot is a hormone therapy...
- The Defense Logistics Agency Medical Supply Chain awarded a $42,779.28 delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits, with final delivery required by July 31, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9Q3Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,212.04 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Lupron Depot 3.75 mg kits. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement valued through December 2026 that supports comprehensive pharmaceutical supply needs across military healthcare systems globally. Lupron Depot is a gonadotropin-releasing hormone agonist used in military medical treatment for conditions including endometriosis and hormone-responsive cancers. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen maintains an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical prime vendor contract demonstrates the contractor's capability to meet federal procurement requirements across multiple therapeutic domains and delivery scales, supporting ongoing military medical readiness and healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.2k | 8/8/25 |